South San Francisco-based Shaman Pharmaceuticals Inc. said it has filed a registration statement with the Securities and Exchange Commission for a public offering, directed principally to institutional investors, of 2 million shares. . . . . Culver City-based Charles David of California appointed Michael A. Rozbruch as chief financial officer. . . . Los Angeles-based Equity Marketing Inc. named Michael J. Welch senior vice president and chief financial officer.
Times Staff and Wire Reports
Copyright © 2019, Los Angeles Times